Loading…
Bone Marrow Failure Disease Research and Treatment Act of 2011
Legislative Progress
Introduced
February 10, 2011
Latest Action
February 18, 2011
Primary Sponsor
Doris O. MatsuiDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
8d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2012 · fourth_quarter · Health Issues
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · fourth_quarter · Science/Technology
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defence Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · fourth_quarter · Budget/Appropriations
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · fourth_quarter · Medical/Disease Research/Clinical Labs
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · third_quarter · Health Issues
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · third_quarter · Science/Technology
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defence Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · third_quarter · Budget/Appropriations
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · third_quarter · Medical/Disease Research/Clinical Labs
S.3295, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · second_quarter · Science/Technology
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defence Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · second_quarter · Budget/Appropriations
No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · second_quarter · Health Issues
No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · second_quarter · Medical/Disease Research/Clinical Labs
No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · first_quarter · Medical/Disease Research/Clinical Labs
No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research No Bill #, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · first_quarter · Science/Technology
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012 , biomedical research HR 2055, Consolidated Appropriations Bill, FY 2012, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · first_quarter · Health Issues
No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research No Bill #, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2012 · first_quarter · Budget/Appropriations
No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research No Bill #, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · fourth_quarter · Science/Technology
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012 , biomedical research HR 2055, Consolidated Appropriations Bill, FY 2012, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · fourth_quarter · Medical/Disease Research/Clinical Labs
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2055, Consolidated Appropriations Bill, FY 2012, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · fourth_quarter · Health Issues
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR2055, Consolidated Appropriations Bill, FY 2012, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · fourth_quarter · Budget/Appropriations
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2055, Consolidated Appropriations Bill, FY 2012, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · third_quarter · Science/Technology
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012 , biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · third_quarter · Medical/Disease Research/Clinical Labs
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · third_quarter · Budget/Appropriations
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · third_quarter · Health Issues
S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · third_quarter · Medical/Disease Research/Clinical Labs
Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. Medicare Physician Fee Schedule; Medicare Reimbursement for Drugs and Biologicals; Medicare Coverage Policies and Hospital Outpatient Payment System. Implementation of Patient Protection and Affordable Care Act. Hematology and Oncology drug research and approval issues. S 296 Preserving Access to Life-Saving Medications Act. Education Appropriations.
Client expense: Not reported · Firm income: Not reported
2011 · third_quarter · Medicare/Medicaid
Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. Medicare Physician Fee Schedule; Medicare Reimbursement for Drugs and Biologicals; Medicare Coverage Policies and Hospital Outpatient Payment System. Implementation of Patient Protection and Affordable Care Act. Hematology and Oncology drug research and approval issues. S 296 Preserving Access to Life-Saving Medications Act. Education Appropriations.
Client expense: Not reported · Firm income: Not reported
2011 · third_quarter · Budget/Appropriations
Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. Medicare Physician Fee Schedule; Medicare Reimbursement for Drugs and Biologicals; Medicare Coverage Policies and Hospital Outpatient Payment System. Implementation of Patient Protection and Affordable Care Act. Hematology and Oncology drug research and approval issues. S 296 Preserving Access to Life-Saving Medications Act. Education Appropriations.
Client expense: Not reported · Firm income: Not reported
2011 · third_quarter · Pharmacy
Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. Medicare Physician Fee Schedule; Medicare Reimbursement for Drugs and Biologicals; Medicare Coverage Policies and Hospital Outpatient Payment System. Implementation of Patient Protection and Affordable Care Act. Hematology and Oncology drug research and approval issues. S 296 Preserving Access to Life-Saving Medications Act. Education Appropriations.
Client expense: Not reported · Firm income: Not reported
2011 · second_quarter · Medical/Disease Research/Clinical Labs
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act S.Res. 172, resolution designating May 2011 as National Cancer Research Month
Client expense: $30,000 · Firm income: Not reported
2011 · second_quarter · Health Issues
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Continuing Resolutions, FY 2011
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · second_quarter · Medical/Disease Research/Clinical Labs
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Continuing Resolutions, FY 2011
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · second_quarter · Budget/Appropriations
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Continuing Resolutions, FY 2011
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · second_quarter · Science/Technology
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2012 , biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Continuing Resolutions, FY 2011
Client expense: Not reported · Firm income: $20,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · second_quarter · Medical/Disease Research/Clinical Labs
Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2011 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues Embryonic Stem Cell Research and Regenerative Medicine Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research S. 296, the Preserving Access to Life-Saving Medications Act
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
2011 · first_quarter · Medical/Disease Research/Clinical Labs
Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
| Democratic |
| IN |
| Anna G. Eshoo | Democratic | CA |
| Barney Frank | Democratic | MA |
| Bruce L. Braley | Democratic | IA |
| C. A. Dutch Ruppersberger | Democratic | MD |
| Carolyn B. Maloney | Democratic | NY |
| Charles A. Gonzalez | Democratic | TX |
| Chris Van Hollen | Democratic | MD |
| Christopher Murphy | Democratic | CT |
| David Loebsack | Democratic | IA |
| Diana DeGette | Democratic | CO |
| Edolphus Towns | Democratic | NY |
| Eleanor Holmes Norton | Democratic | DC |
| Eliot L. Engel | Democratic | NY |
| Eni F. H. Faleomavaega | Democratic | AS |
| Fortney Pete Stark | Democratic | CA |
| James P. McGovern | Democratic | MA |
| Janice D. Schakowsky | Democratic | IL |
| Jason Altmire | Democratic | PA |
| Jesse L. Jackson Jr. | Democratic | IL |
| Jim McDermott | Democratic | WA |
| Jo Ann Emerson | Republican | MO |
| Joe Courtney | Democratic | CT |
| Joe Donnelly | Democratic | IN |
| John Barrow | Democratic | GA |
| John F. Tierney | Democratic | MA |
| John Lewis | Democratic | GA |
| John W. Olver | Democratic | MA |
| Keith Ellison | Democratic | MN |
| Marcia L. Fudge | Democratic | OH |
| Mark S. Critz | Democratic | PA |
| Maurice D. Hinchey | Democratic | NY |
| Mazie K. Hirono | Democratic | HI |
| Michael H. Michaud | Democratic | ME |
| Michael M. Honda | Democratic | CA |
| Nita M. Lowey | Democratic | NY |
| Richard E. Neal | Democratic | MA |
| Rush Holt | Democratic | NJ |
| Russ Carnahan | Democratic | MO |
| Sander M. Levin | Democratic | MI |
| Stephen F. Lynch | Democratic | MA |
| Steve Cohen | Democratic | TN |
| Tammy Baldwin | Democratic | WI |
| Thaddeus McCotter | Republican | MI |
| Tim Holden | Democratic | PA |
| Tim Ryan | Democratic | OH |
| Timothy H. Bishop | Democratic | NY |
| Todd Russell Platts | Republican | PA |
| Tom Latham | Republican | IA |
| William L. Owens | Democratic | NY |
| Wm. Lacy Clay | Democratic | MO |
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE